Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.9766
-0.0634 (-6.10%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Outlook Therapeutics Market Cap
Outlook Therapeutics has a market cap or net worth of $182.62 million as of July 31, 2026. Its market cap has increased by 107.88% in one year.
Market Cap
182.62M
Enterprise Value
202.06M
1-Year Change
107.88%
Ranking
Category
Stock Price
$0.98
ChartMarket Cap Chart
Since June 14, 2016, Outlook Therapeutics's market cap has increased from $97.37M to $182.62M, an increase of 87.56%. That is a compound annual growth rate of 6.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 182.62M | 80.28% |
| Dec 31, 2025 | 101.30M | 115.21% |
| Dec 31, 2024 | 47.07M | -54.10% |
| Dec 29, 2023 | 102.54M | -63.01% |
| Dec 30, 2022 | 277.20M | -9.11% |
| Dec 31, 2021 | 304.99M | 84.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Greenwich LifeSciences | 204.03M |
| Whitehawk Therapeutics | 203.57M |
| Keros Therapeutics | 200.29M |
| Atrium Therapeutics | 194.66M |
| Alpha Cognition | 192.92M |
| AN2 Therapeutics | 188.72M |
| Minerva Neurosciences | 188.22M |
| NovaBridge Biosciences | 186.77M |